These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 37949994)

  • 1. Biomarkers in amyotrophic lateral sclerosis: current status and future prospects.
    McMackin R; Bede P; Ingre C; Malaspina A; Hardiman O
    Nat Rev Neurol; 2023 Dec; 19(12):754-768. PubMed ID: 37949994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis.
    Feldman EL; Goutman SA; Petri S; Mazzini L; Savelieff MG; Shaw PJ; Sobue G
    Lancet; 2022 Oct; 400(10360):1363-1380. PubMed ID: 36116464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging molecular biomarker targets for amyotrophic lateral sclerosis.
    Costa J; de Carvalho M
    Clin Chim Acta; 2016 Apr; 455():7-14. PubMed ID: 26774696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications.
    Sanchez-Tejerina D; Llaurado A; Sotoca J; Lopez-Diego V; Vidal Taboada JM; Salvado M; Juntas-Morales R
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis.
    Goutman SA; Hardiman O; Al-Chalabi A; Chió A; Savelieff MG; Kiernan MC; Feldman EL
    Lancet Neurol; 2022 May; 21(5):480-493. PubMed ID: 35334233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.
    Vu LT; Bowser R
    Neurotherapeutics; 2017 Jan; 14(1):119-134. PubMed ID: 27933485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid and blood exosomes as biomarkers for amyotrophic lateral sclerosis; a systematic review.
    Darabi S; Ariaei A; Rustamzadeh A; Afshari D; Charkhat Gorgich EA; Darabi L
    Diagn Pathol; 2024 Mar; 19(1):47. PubMed ID: 38429818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS.
    Goyal NA; Berry JD; Windebank A; Staff NP; Maragakis NJ; van den Berg LH; Genge A; Miller R; Baloh RH; Kern R; Gothelf Y; Lebovits C; Cudkowicz M
    Muscle Nerve; 2020 Aug; 62(2):156-166. PubMed ID: 31899540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid biomarkers for amyotrophic lateral sclerosis: a review.
    Irwin KE; Sheth U; Wong PC; Gendron TF
    Mol Neurodegener; 2024 Jan; 19(1):9. PubMed ID: 38267984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in amyotrophic lateral sclerosis.
    Turner MR; Kiernan MC; Leigh PN; Talbot K
    Lancet Neurol; 2009 Jan; 8(1):94-109. PubMed ID: 19081518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.
    Menke RA; Körner S; Filippini N; Douaud G; Knight S; Talbot K; Turner MR
    Brain; 2014 Sep; 137(Pt 9):2546-55. PubMed ID: 24951638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurophysiological indices in amyotrophic lateral sclerosis correlate with functional outcome measures, staging and disease progression.
    Barp A; Lizio A; Gerardi F; Tarlarini C; Mauro L; Sansone VA; Lunetta C
    Clin Neurophysiol; 2021 Jul; 132(7):1564-1571. PubMed ID: 34023632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis.
    Dreger M; Steinbach R; Otto M; Turner MR; Grosskreutz J
    J Neurol Neurosurg Psychiatry; 2022 Apr; 93(4):422-435. PubMed ID: 35105727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiological biomarkers in amyotrophic lateral sclerosis.
    Vucic S; Rutkove SB
    Curr Opin Neurol; 2018 Oct; 31(5):640-647. PubMed ID: 30080715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A prognostic biomarker in amyotrophic lateral sclerosis].
    Mitsumoto H; Saito T
    Rinsho Shinkeigaku; 2018 Dec; 58(12):729-736. PubMed ID: 30487362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of surface electromyography in amyotrophic lateral sclerosis: A systematic review.
    Bashford J; Mills K; Shaw C
    Clin Neurophysiol; 2020 Apr; 131(4):942-950. PubMed ID: 32044239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature.
    Gagliardi D; Meneri M; Saccomanno D; Bresolin N; Comi GP; Corti S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biomarkers for amyotrophic lateral sclerosis].
    Tokuda T
    Brain Nerve; 2012 May; 64(5):515-23. PubMed ID: 22570065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.